Scientific American Examines Response To DRC Ebola Outbreak, Use Of Experimental Vaccines

Scientific American: How Ebola Vaccines Have Helped to Usher In a New Era in the Outbreak Response
“…At home in Guinea, [physician Alhassane Touré] had headed up a very successful Ebola vaccine effort three years earlier, helping to deploy an experimental shot after the West African crisis had already gripped the region. But this time around [in the Democratic Republic of Congo], his team had access not just to the experimental vaccine, but also to financial support that would allow them to offer the inoculation near the start of an Ebola outbreak — and try to contain it relatively early…” (Maron, 6/23).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.